Search for 'Provider:American Journal of Hematology,'

Early mortality in multiple myeloma: the time-dependent impact of comorbidity: A population-based study in 621 real-life patients.

By Martínez López, Joaquín | Lahuerta Palacios, Juan José . American journal of hematology, 2016 . 91(7):700-4. , Formato Vancouver: Ríos Tamayo R, Sáinz J, Martínez López J, Puerta JM, Chang DY, Rodríguez T et al. Early mortality in multiple myeloma: the time-dependent impact of comorbidity: A population-based study in 621 real-life patients. Am J Hematol. 2016 Jul;91(7):700-4.

Place Hold on Early mortality in multiple myeloma: the time-dependent impact of comorbidity: A population-based study in 621 real-life patients.

Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor?.

By Martínez López, Joaquín. American journal of hematology, 2014 . 89(11):E206-11. , Formato Vancouver: García-Gutiérrez V, Puerta JM, Maestro B, Casado Montero LF, Muriel A, Molina Hurtado JR et al. Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor? Am J Hematol. 2014 Nov;89(11):E206-11.

Place Hold on Do chronic myeloid leukemia patients with late "warning" responses benefit from "watch and wait" or switching therapy to a second generation tyrosine kinase inhibitor?.

Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study.

By Lahuerta Palacios, Juan José . American journal of hematology, 2014 . 89(4):355-62. , Formato Vancouver: Morabito F, Bringhen S, Larocca A, Wijermans P, Victoria Mateos M, Gimsing P et al. Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study. Am J Hematol. 2014 Apr;89(4):355-62.

Place Hold on Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study.

Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse.

By Vivanco Martínez, José Luis. American Journal of Hematology, 2013 . 88(5):359-64. , Formato Vancouver: Martínez-Laperche C, Gómez-García AM, Lassaletta Á, Moscardó C, Vivanco JL,Molina J et al. Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse. Am J Hematol. 2013 May;88(5):359-64.

Place Hold on Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse.

Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience.

By Martínez Sánchez, María Pilar. American Journal of Hematology, 2012 . 87(6):631-4. , Formato Vancouver: Barba P, Sampol A, Calbacho M, González J, Serrano J, Martínez-Sánchez P, et al. Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience. Am J Hematol. 2012 Jun;87(6):631-4.

Place Hold on Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience.